Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_provenance.
- NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_assertion description "[This review examines the potential of growth factors and cytokines such as M-CSF, IL-6 and IL-10 as tumour markers as well as the over expression of oncogenes such as HER-2/neu in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_provenance.
- NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_assertion evidence source_evidence_literature NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_provenance.
- NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_assertion SIO_000772 8312203 NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_provenance.
- NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_assertion wasDerivedFrom befree-20150227 NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_provenance.
- NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_assertion wasGeneratedBy ECO_0000203 NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP505068.RA9hcwXUgyyDJw-P2hYFNXmS7cU7iL4-CysTrt2IJlPm4130_provenance.